Robert Kleiman expands role at ERT
Adds chief medical officer to current role as vp of global cardiology
Prior to joining ERT in April 2004, Dr Kleiman had worked for ERT as an independent contractor through his cardiology and cardiac electrophysiology practice since 1994. ERT’s cardiology group has more than tripled in size since 2004.
In addition to his current duties, Dr Kleiman will take an increasing consulting and sales role.
Commenting on his appointment, Dr Kleiman said: ‘I have enjoyed my long association with ERT and very much look forward to working with our customers and staff in my new role of working more closely with sponsors to ensure the efficacy and safety of new drugs.’
You may also like
Regulatory
Overcoming CMC challenges in cell and gene therapy: part II
Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC challenges inherent in producing cell and gene therapy (CGT) drugs
Regulatory
Overcoming CMC challenges in cell and gene therapy: part I
Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC challenges inherent in producing cell and gene therapy (CGT) drugs